Study of the safety and immunogenicity of the synthetic malaria SPf66 vaccine in children aged 1–14 years
- 1 January 1992
- Vol. 10 (3), 175-178
- https://doi.org/10.1016/0264-410x(92)90008-8
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The first field trials of the chemically synthesized malaria vaccine SPf66: safety, immunogenicity and protectivityVaccine, 1992
- A specific T‐cell receptor genotype preference in the immune response to a synthetic Plasmodium falciparum malaria vaccineParasite Immunology, 1992
- Genetic control of the immune response to a synthetic vaccine against Plasmodium falciparumParasite Immunology, 1991
- Studies on the humoral immune response to a synthetic vaccine against Plasmodium falciparum malariaClinical and Experimental Immunology, 1991
- Studies in Owl Monkeys Leading to the Development of a Synthetic Vaccine against the Asexual Blood Stages of Plasmodium FalciparumThe American Journal of Tropical Medicine and Hygiene, 1990
- How much malaria is there worldwide?Parasitology Today, 1989
- A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malariaNature, 1988
- Induction of protective immunity against experimental infection with malaria using synthetic peptidesNature, 1987
- Malaria — Resurgence, Resistance, and ResearchNew England Journal of Medicine, 1983
- Malaria — Resurgence, Resistance, and ResearchNew England Journal of Medicine, 1983